BAYER CEO: ‘WE DON’T MAKE MEDICINE FOR POOR INDIANS’

In a crass yet frank admission, Bayer CEO Marijn Dekkers said the company’s new cancer drug, Nexavar, is not “for Indians,” but “for western patients who can afford it.” The statement came in the wake in a recent ruling by an Indian court that certain life-saving drugs could be produced and distributed at 97% of the brand-name price.

Read More >> BAYER CEO: ‘WE DON’T MAKE MEDICINE FOR POOR INDIANS’

Obamacare, It’s for the Children. A Glimpse into the Future? Shortage and Rationing of Life-Saving Drugs

Obamacare, It’s for the Children. A Glimpse into the Future? Shortage and Rationing of Life-Saving Drugs

UPDATE 1-Roche drug combats children's brain tumors

An experimental drug being developed by Roche Holding AG (ROG.VX) showed promising results in a small, early stage trial involving children with medulloblastoma, the most common type of malignant brain tumor in children.

UPDATE 1-Roche drug combats children's brain tumors

Medication Stolen From Wyo. Cancer Kid

A routine trip to a Colorado Target store has left a Wyoming mother and her son who is battling leukemia fuming at the theft of his life-saving medication.

Kids who have survived cancer can tolerate Ritalin

Despite previous studies suggesting that childhood cancer survivors with attention and learning problems have a lot of side effects while taking methylphenidate (marketed as Ritalin and other names), most such children do well on the drug, according to a new study.

More >> Kids who have survived cancer can tolerate Ritalin

Revolutionary new treatment regimen identified for pediatric Hodgkin's lymphoma

Researchers at Hasbro Children's Hospital in Providence, RI have identified a revolutionary new treatment regimen for pediatric Hodgkin's lymphoma, the third most common cancer in children. Led by the director of pediatric hematology/oncology at Hasbro Children's Hospital, Cindy Schwartz, MD, the team of researchers developed a chemotherapy regimen that combined the effectiveness of dose-dense drug delivery with a reduction in long-term risks traditionally presented by high dose chemotherapy.

More >> Revolutionary new treatment regimen identified for pediatric Hodgkin's lymphoma